Dr. Paul R. Johnston has been leading Exponent as CEO since May 28, 2009. With a Ph.D. in Engineering, he brings a strong technical background to the company. His leadership style focuses on aligning management incentives with long-term interests of...

Dr. Paul R. Johnston has been leading Exponent as CEO since May 28, 2009. With a Ph.D. in Engineering, he brings a strong technical background to the company. His leadership style focuses on aligning management incentives with long-term interests of stockholders, ensuring that the company aims for revenue growth and profitability. In 2023, Dr. Johnston received a total compensation of $1,697,125, which reflects his contributions to Exponent's performance. His bonus structure is tied to performance metrics like revenue increases, which emphasizes his dedication to driving success. Notably, Dr. Johnston had a compensation peak in 2018 when his total reached over $2.4 million. Under his guidance, Exponent has shown steady growth and resilience in competitive markets. Interestingly, he has not vested any stock or options in recent years, signifying a focus on cash-governed incentives rather than stock performance alone. This approach suggests that Dr. Johnston prioritizes operational performance while managing company resources effectively.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

E

Dr. Paul R. Johnston

CEO of Exponent

Education

Ph.D. in Engineering

Field of Expertise

Technology & Engineering - Engineering

Sector of Economy

Industrials

Born

February 19, 1954 - 71 years ago

CEO of Exponent for

15 years 11 months (May 2009 - Present)

Previous Experience

President and Chief Operating Officer at Exponent, Inc.

Rivals

Competitors/colleagues of Dr. Paul R. Johnston

Holdings

See how much did Dr. Paul R. Johnston make over time.

Dr. Johnston's holdings have seen fluctuations over the years, reflecting his approach to stock options and performance-based incentives. As of 2023, he emphasized cash compensation, having not vested any stock in recent years. His focus has shifted away from stock...

Dr. Johnston's holdings have seen fluctuations over the years, reflecting his approach to stock options and performance-based incentives. As of 2023, he emphasized cash compensation, having not vested any stock in recent years. His focus has shifted away from stock options towards managing Exponent's operational success. This strategy highlights his alignment with the company's long-term goals rather than short-term stock price movements. Historical records show that in 2018, he had a peak compensation of over $2.4 million, reflecting the company's strong performance that year. Since then, there has been a significant change in his compensation structure, steering clear from stock reliance. His holdings strategy demonstrates a personal commitment to the company's sustained operational health rather than speculative gains.

Total Stock Sold

$37.10M

EXPO

$37.10M

1,082,084 EXPO shares

What if they kept their stock?

If Dr. Paul R. Johnston didn't sell their stock, today they would have:
Extra EXPO1,082,084 shares worth $67.87M.
This is 82.94% and $30.77M more than what they got when they sold the stock.

Charitable Transactions

EXPO

169,336 shares

EXPO

Recent Charitable Transactions

EXPO

21,336 shares

EXPO

Nov 13, 2024

Charity

EXPO

10,000 shares

EXPO

Dec 31, 2021

Charity

EXPO

10,000 shares

EXPO

Nov 27, 2020

Charity

EXPO

10,000 shares

EXPO

Oct 25, 2017

Charity

EXPO

$605.76K

EXPO at $50.48/share

Aug 2, 2016

Charity

EXPO

$624.00K

EXPO at $52.00/share

Oct 28, 2015

Charity

Insider Trading

See recent insider trades of Dr. Paul R. Johnston.

EXPO

$543.85K

EXPO at $95.41/share

Jan 3, 2025

Sale

EXPO

$123.54K

EXPO at $95.03/share

Nov 20, 2024

Sale

EXPO

$688.26K

EXPO at $98.32/share

Nov 15, 2024

Sale

EXPO

21,336 shares

EXPO

Nov 13, 2024

Charity

EXPO

$726.82K

EXPO at $103.83/share

Nov 12, 2024

Sale

EXPO

$725.54K

EXPO at $103.65/share

Nov 7, 2024

Sale

EXPO

$1.46M

EXPO at $104.60/share

Nov 6, 2024

Sale

EXPO

$667.36K

EXPO at $95.34/share

Jun 20, 2024

Sale

EXPO

$668.52K

EXPO at $95.50/share

Jun 17, 2024

Sale

EXPO

$670.84K

EXPO at $95.83/share

Jun 6, 2024

Sale

Compensation History

See how much did Dr. Paul R. Johnston make over time.

In 2023, Dr. Johnston's total compensation was $1,697,125, comprised of a base salary of $900,000 and a performance-based bonus of $720,000. His bonus system is designed to reflect the company's performance, emphasizing metrics like revenue and profitability. This rewards him for meeting specific goals, aligning his interests with those of the company's stakeholders. Over the years, his total compensation peaked in 2018 at over $2.4 million, emphasizing a strong performance linked to Exponent's operational growth. The focus on a cash-heavy compensation package, especially in recent years, illustrates a strategic shift towards immediate financial performance rather than long-term vested stock options. Overall, this compensation structure signifies his commitment to driving Exponent's success through sustainable and measurable results.

Year

2023

Total Compensation

$1.68M

Salary

$900.00K

Board Justification

The compensation philosophy aims to align management's incentives with the long-term interests of stockholders and to retain top talent through competitive compensation packages.

Bonus

$720.00K

Board Justification

The bonus is based on the company's performance metrics including revenue growth and profitability, with a portion settled in cash and a portion in fully vested restricted stock units.

Other

$62.13K

Board Justification

This includes contributions to the defined contribution retirement account and other benefits.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock was reported as vested in 2023 for Dr. Johnston.

Performance Metrics

The performance metrics for determining the compensation include revenue growth, profitability, and leadership contributions.